...
首页> 外文期刊>Molecular and Cellular Biochemistry: An International Journal for Chemical Biology >Role of membrane-associated Ca~(2+) dependent matrix metalloprotease-2 in the oxidant activation of Ca~(2+) ATPase by tertiary butylhydroperoxide
【24h】

Role of membrane-associated Ca~(2+) dependent matrix metalloprotease-2 in the oxidant activation of Ca~(2+) ATPase by tertiary butylhydroperoxide

机译:膜相关的Ca〜(2+)依赖性基质金属蛋白酶-2在叔丁基过氧化氢氧化激活Ca〜(2+)ATPase中的作用

获取原文
获取原文并翻译 | 示例
           

摘要

Treatment of bovine pulmonary artery smooth muscle plasma membrane suspension with the oxidant tert-butylhydroperoxide (t-buOOH) increases Ca~(2+)ATPase activity. The smooth muscle plasma membrane possesses a Ca~(2+) dependent protease activity in the gelatin containing zymogram having an apparent molecular mass of 72 kDa. The 72 kDa protease activity was found to be inhibited by EGTA and the tissue inhibitor of metalloprotease-2 (TIMP-2). Since 72 kDa is the molecular mass of MMP-2 and since in our present study the 72 kDa protease in the gelatin containing zymogram is inhibited by matrix metalloprotease inhibitors, EGTA and TIMP-2, it may be suggested that the 72 kDa protease is the MMP-2. In addition to the increasing Ca~(2+)ATPase activity, t-buOOH also enhances the activity of the membrane associated Ca~(2+) dependent protease that degrades ~(14)C-gelatin. The oxidant triggered protease activity and the Ca~(2+)ATPase activity were found to be prevented by the antioxidant vitamin E, and also by the Ca~(2+) dependent matrix metalloprotease inhibitors: EGTA and TIMP-2. Adding MMP-2 to the smooth muscle plasma membrane suspension caused an increase in Ca~(2+)ATPase activity and pretreatment with TIMP-2 prevents the increase in Ca~(2+)ATPase activity. Combined treatment of the smooth muscle plasma membrane with low doses of MMP-2 and t-buOOH augments further the Ca~(2+)ATPase activity caused by the respective doses of either t-buOOH or MMP-2. Pretreatment with TIMP-2 prevents the increase in Ca~(2+)ATPase activity elicited by the low doses of MMP-2 and/or t-buOOH.
机译:用叔丁基氢过氧化物(t-buOOH)处理牛肺动脉平滑肌质膜悬浮液可提高Ca〜(2+)ATPase活性。平滑肌质膜在表观分子量为72kDa的含明胶的酶谱中具有Ca〜(2+)依赖性蛋白酶活性。发现72kDa的蛋白酶活性被EGTA和金属蛋白酶-2的组织抑制剂(TIMP-2)抑制。由于72 kDa是MMP-2的分子量,并且由于在我们目前的研究中,含明胶的酶谱图中的72 kDa蛋白酶被基质金属蛋白酶抑制剂EGTA和TIMP-2抑制,因此可以认为72 kDa蛋白酶是MMP-2的分子量。 MMP-2。除增加的Ca〜(2+)ATPase活性外,t-buOOH还增强了与膜相关的Ca〜(2+)依赖性蛋白酶的活性,该蛋白酶降解〜(14)C-明胶。发现氧化剂触发的蛋白酶活性和Ca〜(2+)ATPase活性被抗氧化剂维生素E以及Ca〜(2+)依赖性基质金属蛋白酶抑制剂EGTA和TIMP-2阻止。在平滑肌质膜悬浮液中添加MMP-2导致Ca〜(2+)ATPase活性增加,而TIMP-2预处理可防止Ca〜(2+)ATPase活性增加。低剂量的MMP-2和t-buOOH对平滑肌质膜的联合处理进一步增强了由各自剂量的t-buOOH或MMP-2引起的Ca〜(2+)ATPase活性。用TIMP-2预处理可防止由于低剂量的MMP-2和/或t-buOOH引起的Ca〜(2+)ATPase活性增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号